MOOD — Doseology Sciences Share Price
Last trade - 00:00- CA$4.43m
- CA$3.50m
- CA$0.10m
- 53
- 10
- 60
- 35
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.91 | ||
| Price to Tang. Book | 4.91 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 75.95 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -33.99% | ||
| Return on Equity | -27.08% | ||
| Operating Margin | -526.04% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | 0.02 | 0.04 | 0.1 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Doseology Sciences Inc. specializes in premium functional mushroom supplements that are stacked for targeted results. The Company’s products address wellness needs. The Company, along with its wholly owned subsidiary, Dose Labs Inc., is building a brand focused on mental health and wellness through nutraceutical products. It focuses on making an impact on the mental health pandemic by utilizing and developing functional fungi and plant-derived nutraceutical products. Its functional mushroom products, including tinctures, powders and supplements, are available on doseology.com and throughout various retail chains across Canada. The Company's functional mushroom product line is specifically available in the Rachelle Bery wellness boutique section of both Sobeys and Safeway stores. Its functional mushroom products are also available in Whole Foods Market locations across Canada, Nature's Emporium retail stores, and other stores. It sells its products online through its Website and Amazon.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 25th, 2019
- Public Since
- November 15th, 2021
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 11,077,997
- Address
- Suite 305, 9-3151 Lakeshore Rd, KELOWNA, V1W 3S9
- Web
- https://doseology.com/
- Phone
- +1 7784105195
- Auditors
- DALE MATHESON CARR-HILTON LABONTE LLP
Similar to MOOD
1933 Industries
Canadian Securities Exchange
1CM
Canadian Securities Exchange
Adastra Holdings
Canadian Securities Exchange
Aion Therapeutic
Canadian Securities Exchange
Asia Green Biotechnology
Canadian Securities Exchange
FAQ
As of Today at 20:19 UTC, shares in Doseology Sciences are trading at CA$0.40. This share price information is delayed by 15 minutes.
Shares in Doseology Sciences last closed at CA$0.40 and the price had moved by +25% over the past 365 days. In terms of relative price strength the Doseology Sciences share price has outperformed the Toronto Stock Exchange 300 Composite Index by +9.6% over the past year.
There is no consensus recommendation for this security.
Find out moreDoseology Sciences does not currently pay a dividend.
Doseology Sciences does not currently pay a dividend.
Doseology Sciences does not currently pay a dividend.
To buy shares in Doseology Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.40, shares in Doseology Sciences had a market capitalisation of CA$4.43m.
Here are the trading details for Doseology Sciences:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: MOOD
Based on an overall assessment of its quality, value and momentum Doseology Sciences is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Doseology Sciences. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +76.19%.
As of the last closing price of CA$0.40, shares in Doseology Sciences were trading +49.91% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Doseology Sciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Doseology Sciences' directors